• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice

tetano

Editor, Senior Moderator
Cell Rep


. 2022 Aug 29;111359.
doi: 10.1016/j.celrep.2022.111359. Online ahead of print.
Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice


Shufeng Liu[SUP] 1 [/SUP], Prabhuanand Selvaraj[SUP] 1 [/SUP], Kotou Sangare[SUP] 1 [/SUP], Binquan Luan[SUP] 2 [/SUP], Tony T Wang[SUP] 3 [/SUP]



Affiliations

Abstract

Despite being more transmissible, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant only causes milder diseases in laboratory animals, often accompanied by a lower viral load compared with previous variants of concern. In this study, we report the structural basis for a robust interaction between the receptor-binding domain of the Omicron spike protein and mouse ACE2. We show that pseudovirus bearing the Omicron spike protein efficiently utilizes mouse ACE2 for entry. By comparing viral load and disease severity among laboratory mice infected by a natural Omicron variant or recombinant ancestral viruses bearing either the entire Omicron spike or only the N501Y/Q493R mutations in its spike, we find that mutations outside the spike protein in the Omicron variant may be responsible for the observed lower viral load. Together, our results imply that a post-entry block to the Omicron variant exists in laboratory mice.

Keywords: Balb/c mice; CP: Microbiology; K18-hACE2; Omicron variant; SARS-CoV-2; attenuation.
 
Back
Top Bottom